Related Experiment Video
Updated: Jun 21, 2026
09:03
Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
Nanotechnology controlled drug delivery for treating bone diseases
1Brown University, Division of Engineering, Providence, RI 02912, USA.
Expert Opinion on Drug Delivery
|July 30, 2009
Summary
Nanotechnology significantly advances bone disease treatment and bone regeneration through controlled drug delivery. This review highlights novel nanomaterials and principles for enhanced therapeutic outcomes in bone repair.
Area of Science:
- Biomedical Engineering
- Materials Science
- Drug Delivery Systems
Background:
- Bone diseases pose significant challenges in treatment and regeneration.
- Conventional therapies often have limitations in efficacy and targeted delivery.
- Nanotechnology offers innovative solutions for overcoming these limitations.
Purpose of the Study:
- To review recent experimental progress in applying nanotechnology for bone disease treatment.
- To summarize novel applications of diverse nanomaterials in bone regeneration.
- To emphasize fundamental principles of nanomaterial-based drug delivery for bone repair.
Main Methods:
- Comprehensive literature review of experimental studies.
- Analysis of various nanomaterial types, including nanoparticles and 3D scaffolds.
- Focus on drug delivery systems for bone-specific applications.
Main Results:
- Nanotechnology has demonstrated tremendous growth in treating bone diseases over the past decade.
- Numerous nanomaterials show promise for enhanced bone regeneration.
- Optimized drug delivery systems utilizing nanomaterials improve therapeutic efficacy.
Conclusions:
- Nanotechnology is a transformative approach for treating bone diseases.
- Diverse nanomaterials offer versatile platforms for bone regeneration and drug delivery.
- Further research into fundamental principles will accelerate clinical translation.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...